Nick Lee, general manager of Ipsen Taiwan, Hong Kong, and Macau, shares his journey of building up the affiliate after having separated from their local partner two years ago. Lee also highlights Ipsen’s dedication to Taiwan’s healthcare system by introducing innovative products in its key areas of oncology, neurology, and rare disease.
One of Taiwan’s specific strengths is its clinical trial environment. Whether research is done by local players or MNCs, the quality of studies conducted in the country is always one of the best in Asia
